Mostrele preparatului au fost transportate la Budapesta pe 19 noiembrie.
Specialiștii unguri vor efectua teste de laborator și clinice, iar apoi vor lua o decizie cu privire la utilizarea și licențierea lui.
Sputnik V este primul vaccin din lume împotriva COVID-19. Acesta a fost creat de Centrul rus Gamaleya.
Russian-made Sputnik V coronavirus vaccine samples arrived in Budapest on Thursday.
Foreign Minister of Hungary, Peter Szijjarto, said the vaccine would be examined by Hungarian scientists.
”Sputnik V was brought to the Hungarian official laboratory where Hungarian specialists can examine the vaccine and they can decide on the usage and licensing. This comprehensive examination can start when the Russian manufacturer sends us the complete documentation which we will have soon,” he said.
Dubbed the ‘world’s first’ vaccine against COVID-19, Sputnik V is due to enter civilian circulation from the beginning of 2021.
The product was registered by the Russian Health Ministry and is produced with the financial help of the Russian Direct Investment Fund.
Peter Szijjarto, Foreign Minister of Hungary (Hungarian):
“The vaccine sample that was made in Russia has arrived today. We are the first European country to get this sample. Ten doses have arrived. It was carried out under exceptional conditions within the plane. It was held in permanent -18 Celsius. It was brought to Hungarian official laboratory where Hungarian specialists can examine the vaccine and they can decide on usage and licensing. This comprehensive examination can start when the Russian manufacturer sends us the complete documentation which we will have soon.”
An acquisition by Budapest and entry into the EU market would represent a symbolic win for Russia’s Sputnik V vaccine, which has been criticised by some experts for its rapid pace of approval and limited publicly available information on its efficacy.
The Russian vaccine is not among the portfolio built up by the European Commission for the EU’s 27 member states, including Hungary. The EU executive has struck deals with drugs companies to secure more than 1bn doses of candidate jabs, including the Pfizer-BioNTech product.
If deemed effective, larger shipments could begin from the second half of January, he said. The minister said he was also in talks with a Hungarian pharmaceutical company to see if it would be able to produce the vaccine.
Szijjarto said Hungary was working to obtain vaccines “from as many sources as possible”. Last week, he said the government was also in talks with Israel about procuring the vaccine being developed there, and noted that it could be possible to buy the vaccine developed in China “within weeks or a few months.”
On November 19, Reuters reported citing the European Commission that Brussels is concerned about Hungary’s plans to import and possibly use Russia’s Sputnik V COVID-19 vaccine.
Source: SPUTNIK, RUPTLY TV and TASS